BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-28.93%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$293M
AUM Growth
+$293M
(-34%)
Cap. Flow
+$3.06M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$3.06M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 62.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $95.5M | 32.62% | 8,930,237 | – | – |
|
2
InflaRx
IFRX
$108M
| $64.2M | 21.93% | 1,764,888 | – | – |
|
3
Solid Biosciences
SLDB
$427M
| $53.3M | 18.22% | 1,989,444 | – | – |
|
|
APTX
4
DELISTED
Aptinyx Inc. Common Stock
APTX
| $36.8M | 12.58% | 2,225,092 | – | – |
|
5
Replimune Group
REPL
$422M
| $28.4M | 9.7% | 2,838,968 | – | – |
|
|
MRNS
6
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $14.5M | 4.95% | 5,042,735 +1,065,282 | +27% | +$3.06M |
|